Advance Agrolife H1 FY27 Profit Rises 38% on Revenue Gain

Advance Agrolife Ltd reported H1 FY27 profit after tax of ₹34.3 crore, up 38.4% year on year, as total revenue reached ₹617.6 crore, a 62% increase for the half year ended September 30, 2026. The result shows strong half-year sales growth, although second-quarter operating margins were lower than a year earlier.

What did Advance Agrolife report for H1 FY27?

Advance Agrolife reported total revenue of ₹617.6 crore for the first half of FY27, compared with the corresponding period of the previous financial year. The company said revenue increased 62% year on year, while EBITDA rose 33% to ₹56.9 crore. H1 EBITDA margin stood at 9.2%.

Profit after tax for H1 FY27 was ₹34.3 crore, up 38.4% year on year. The half-year numbers were approved by the board on November 4, 2026, together with the unaudited financial results for the quarter and half year ended September 30, 2026. The filing was accompanied by a limited review from the statutory auditors.

The reported H1 growth followed a substantial increase in the June quarter, for which the company had earlier disclosed revenue of ₹330 crore. The September-quarter result, however, showed that quarterly revenue and profitability moved differently from the half-year trend.

Why did Q2 FY27 margins decline despite higher sales?

Advance Agrolife recorded Q2 FY27 revenue from operations of ₹287.2 crore, up 35% year on year from ₹213 crore, but EBITDA and profit after tax declined. Q2 EBITDA was ₹21.8 crore, down 15% from ₹25.9 crore in the year-ago quarter, while EBITDA margin fell to 7.6% from 12.1%.

Q2 profit after tax was ₹11.8 crore, compared with ₹15.9 crore in Q2 FY26, representing a decline of about 26%. Revenue also declined 13% sequentially from the June 2026 quarter, according to the financial presentation. The available disclosures quantify the margin movement but do not specify the individual cost or pricing factors behind it.

The difference between the quarterly and half-year figures is relevant for investors assessing the result. While H1 revenue, EBITDA and profit all grew from the prior-year period, the September-quarter margin contraction limited the conversion of revenue growth into operating and net profit during the quarter.

What expansion and solar-project updates did the board approve?

Advance Agrolife said it plans to commission a new plant by Q4 FY27 to increase capacity and diversify its product portfolio. Its stated expansion programme includes a fourfold scale-up in 2,4-D herbicides, which the company has identified as a driver of volume and top-line growth.

The board also approved registration for an approximately 4 MW captive solar project in Bikaner, Rajasthan, with the Rajasthan Renewable Energy Corporation Limited. The November 4 filing referred to a revised registration for the project. The announcement establishes the regulatory registration update, but does not provide project cost, commissioning timing or expected financial savings.

The company also reported export operations across 14 countries and a distribution network spanning 19 states in India. It has set an objective of raising exports from about 2% of revenue currently to 20% by FY29, supported by higher volumes and wider product diversification.

How does the update matter for investors and the agrochemical industry?

Advance Agrolife's result presents two distinct operating signals. The 62% H1 revenue increase and 38.4% rise in H1 profit indicate stronger sales over the first six months of FY27. But the Q2 decline in EBITDA margin and profit means investors will also track whether the company can improve operating profitability as revenue expands.

The disclosed capacity additions are significant because they are intended to support production volumes and product diversification. The company holds more than 410 registrations with India's Central Insecticides Board, including 380 formulations and 30 technical registrations. The company has described these registrations as important because a customer changing the manufacturing source can require fresh stability testing and regulatory filings.

The planned solar project adds an operational development alongside the financial result. However, the filing does not quantify its capital expenditure, power generation, cost benefit or commencement date. No share-price movement or market reaction was included in the disclosures, so the update provides no basis for measuring an immediate stock-market impact.

Conclusion

Advance Agrolife delivered strong H1 FY27 growth, with revenue rising to ₹617.6 crore and profit after tax increasing to ₹34.3 crore. The September quarter nevertheless showed lower EBITDA, net profit and margins despite higher year-on-year revenue, making the pace of margin recovery an important part of the financial picture.

The next disclosed milestones are commissioning of the new plant by Q4 FY27, progress on the fourfold 2,4-D herbicide scale-up, and execution of the approximately 4 MW captive solar project registration in Rajasthan. Investors will also watch progress towards the company's FY29 target of increasing the export revenue share from around 2% to 20%.